AIP
BIOA

Ameritas Investment Partners’s BioAge Labs BIOA Stock Holding History

Ameritas Investment Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.2K Buy
3,190
+720
+29% +$13K ﹤0.01% 1988
2026
Q1 		$43.2K Buy
2,470
+1,201
+95% +$23.1K ﹤0.01% 2173
2025
Q4 		$16.8K Hold
1,269
– – ﹤0.01% 2714
2025
Q3 		$7.46K Hold
1,269
– – ﹤0.01% 3001
2025
Q2 		$5.24K Hold
1,269
– – ﹤0.01% 3103
2025
Q1 		$4.77K Hold
1,269
– – ﹤0.01% 2980
2024
Q4 		$7.35K Buy
+1,269
New +$21.9K ﹤0.01% 2977

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Ameritas Investment Partners's BIOA Position: Q2 2026 in Review

Ameritas Investment Partners increased its BioAge Labs (BIOA) stake by 29% in Q2 2026, buying an estimated $13K and bringing the position to 3,190 shares worth $78.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.

Ameritas Investment Partners first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Ameritas Investment Partners held 3,190 shares of BioAge Labs worth $78.2K as of Q2 2026.
  • Ameritas Investment Partners bought 720 BioAge Labs shares in Q2 2026, an estimated $13K.
  • BioAge Labs made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1988 holding.
  • Ameritas Investment Partners first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.